Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Nitropress, and what generic Nitropress alternatives are available?

Nitropress is a drug marketed by Abbvie, Abbott, and Hospira. and is included in four NDAs.

The generic ingredient in NITROPRESS is sodium nitroprusside. There are one thousand three hundred and seventy-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.

Summary for Tradename: NITROPRESS

Suppliers / Packagers: see list2
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NITROPRESS at DailyMed

Pharmacology for Tradename: NITROPRESS

Drug ClassVasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
sodium nitroprusside
INJECTABLE;INJECTION018450-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
sodium nitroprusside
INJECTABLE;INJECTION070566-001Jun 9, 1986DISCNNoNo► Subscribe► Subscribe
sodium nitroprusside
INJECTABLE;INJECTION071555-001Nov 16, 1987DISCNNoNo► Subscribe► Subscribe
sodium nitroprusside
INJECTABLE;INJECTION071961-001Aug 1, 1988APRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Formulary management
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus